Marino Michael F III

Marino Michael F III is listed in filings as See Remarks at NewAmsterdam Pharma Company N.V.. This profile follows SEC Form 4 activity through Jun 3, 2025, including 2 public disclosures. Recent filings connect the profile to NewAmsterdam Pharma Company N.V. (NAMS). The current snapshot covers public activity from Jun 3, 2025. Reported amounts are shown as $5.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.